[The concept of substrate-close basic symptoms and its significance for the theory and therapy of schizophrenic diseases].
D001288:Attention / Q000502:physiology; D003072:Cognition Disorders / Q000523:psychology; D006801:Humans; D019965:Neurocognitive Disorders / Q000523:psychology; D018377:Neurotransmitter Agents / Q000378:metabolism; D010553:Personality Development; D011379:Prognosis; D011581:Psychological Tests; D012559:Schizophrenia / Q000628:therapy*; D012565:Schizophrenic Psychology; D012569:Schizotypal Personality Disorder / Q000523:psychology*; D012917:Social Adjustment; D013850:Thinking / Q000502:physiology
D018377:Neurotransmitter Agents
Das Konzept substratnaher Basissymptome und seine Bedeutung für Theorie und Therapie schizophrener Erkrankungen.